In head and neck squamous cell carcinoma, PD-L1 is preferentially expressed in CD44+ tumor-initiating cells and inhibits IFN-γ secretion by tumor-infiltrating lymphocytes (TILs) incubated with CD44+ cells [26]. Here, IFNG is linked to neoplasm.